ISIMM Web

Promoting knowledge, innovation, and excellence in slide-based techniques. Leadership and education with the overarching goal of improving patient care.

[Canadian Biomarker Quality Assurance @cbqapcab]

https://t.co/2EdlJlU9hC has a new module for #BreastPath #HER2 #IHC scoring; compare yourself with experts or your peers on 20 cases.

Login or create a new account (free) at https://t.co/ZmG9C1fasO and select the "HER2 Breast Ca" readout module to get started.

#PathTwitter

[ISIMM Web @ISIMMweb]

There's still time to register for @JLHornick's presentation: https://t.co/bDRqgE8T19
👇👇👇

[Andrew Bellizzi 🇺🇦 @IHC_guy]

Thrilled to welcome everyone to tomorrow morning's (11 am ET) @ISIMMweb webinar in which my brother by another mother, @JLHornick, will regale us with tale after tale of sarcomas solved by next-generation IHC.

Link to register:
https://t.co/WV6GbPCQj3

[ISIMM Web @ISIMMweb]

What an #amazing lineup! 👇

Register here: https://t.co/EJB5CoRKrQ

#AIMP2022

[Andrew Bellizzi 🇺🇦 @IHC_guy]

Check out this awesome agenda for tomorrow's course!!!

Registration is still open: https://t.co/kc2kLB7F5Q

See you online in the am!

@HeadandNeckPath

[Appl Immunohistochem Mol Morphol Journal @AimmJournal]

Join us Wednesday! @ISIMMweb 2022 Series - First up is Megan Troxell @megantpathology - Diagnostic Immunohistochemistry in Breast Pathology | Wed. Jan 12 @1100 ET.: https://t.co/MviAwO9v85

#IHCpath #BreastPath #PathTwitter

[Andrew Bellizzi 🇺🇦 @IHC_guy]

We're getting the band back together!!!

Please join @ISIMMweb tomorrow morning for our 1st webinar of the semester; my dear friend @megantpathology will be discussing Applications of Diagnostic IHC in Breast Pathology.

Great way to keep #abreast of developments in the field.

[ISIMM Web @ISIMMweb]

Webinar: "Significance of Pathologist’s #Readout for #IHC #Biomarker Assays: Art or Science?"

Who: Emina E. Torlakovic, MD, PhD (@DrETorlakovic)

When: Wed July 14, 2021 - 11:00am EDT

Where: 👇(complimentary)
https://t.co/rMId5qD6Oy

@AimmJournal @IHC_guy @DrCarolCheung

[Andrew Bellizzi 🇺🇦 @IHC_guy]

@JMGardnerMD @KMirza @Sara_Jiang @CArnold_GI @kis_lorand @Chucktowndoc @Teclis82 @PathPod @smlungpathguy @natasharekhtman @IHC_NordiQC @AimmJournal @ISIMMweb @UIPathology @MattGosseMD @DennisOMalleyMD

[Peter Louis, M.D., J.D., FCAP⚕️🔬🧬 🖥 🔢 📊⚖️ @MDJDPathology]

Wed June 16 1100 EST

International Society for #IHC #Molecular #Morphology

Trouble-Shooting #Diagnostic #Immunohisrochemistry Testing

#Histology
#Pathology
#Parhologist
#PathResident
#PathTwitter
⁦⁦@ISIMMweb⁩

Webinar Registration below https://t.co/sq98lTjibe

[ISIMM Web @ISIMMweb]

Webinar: "Trouble-Shooting Diagnostic #IHC Testing"

Who: Richard W. Cartun, MS, PhD

When: Wed June 16, 2021 - 11:00am EDT

Where: 👇(complimentary registration)
https://t.co/i2LnJ9YaJ8

@AimmJournal @DrETorlakovic @IHC_guy @DrCarolCheung

[Appl Immunohistochem Mol Morphol Journal @AimmJournal]

Here are the other 4!

#IHCpath #GownsIHClaw
@ISIMMweb @amgown

[ISIMM Web @ISIMMweb]

Webinar: "#ISIMM A Four Decade Sojourn Through Markers of Carcinomas of Unknown Primary"

Who: Allen Gown, MD (@amgown)

When: Wed May 26, 2021 - 11:00am EDT

Where: 👇 (complimentary registration)
https://t.co/t3BTrXvW7k

@AimmJournal @DrETorlakovic @IHC_guy @DrCarolCheung

[ISIMM Web @ISIMMweb]

#ISIMM Webinar: "#PDL1 Testing Across Different Platforms and Different Purposes; The ABCs of Fit-for- Purpose in #IHC"

Who: Carol Cheung, MD, PhD, JD (@drcarolcheung)

When: Wed April 14, 2021 - 11:00am EDT

Where: 👇 (complimentary registration)
https://t.co/kZLuBrwYfK

[Andrew Bellizzi 🇺🇦 @IHC_guy]

Here's a fun game.

I just validated this stain.

What is it and why?

[Andrew Bellizzi 🇺🇦 @IHC_guy]

Now that #BeltGate is firmly behind us . . .

@UIPathology has much to celebrate tonight, as @IAbukhiran and @MattGosseMD both received Certificates of Merit for their entries into the Stowell-Orbison Award Competition.

https://t.co/RIM6I9aSuM

[Andrew Bellizzi 🇺🇦 @IHC_guy]

IHC is incredibly charming but no longer a cottage industry😊

I was @TheUSCAP this am discussing @Pathologists new Ki67 PT program when the spirit moved me to dash off to the lab to find our initial Ki67 "validation."

How it started ... where it's going ... still a ways to go!

[ISIMM Web @ISIMMweb]

Meet the #Experts: ER & PR Testing In Breast Cancer, High-Grade Neoplasms of Uncertain Lineage & IHC.

Who: Drs. Megan Troxell, Andrew Bellizzi @IHC_guy, Paul Swanson.

When: Wednesday March 17, 2021, 11:00 am EDT

Where: 👇 (complimentary registration)
https://t.co/IADtrdUW3Q

[Kamran Mirza MD PhD - کامران مرزا @KMirza]

@IHC_guy @YouTube @JMGardnerMD @Sara_Jiang @CArnold_GI @MArnold_PedPath @sanamloghavi @Chucktowndoc @Teclis82 @ISIMMweb @AimmJournal This is awesome! Bookmarking it :) #PathTweetAward for Wesley Estrada and @IHC_guy

[Florida Man @JP_ReynoldsMD]

@IHC_guy @YouTube @JMGardnerMD @KMirza @Sara_Jiang @CArnold_GI @MArnold_PedPath @sanamloghavi @Chucktowndoc @Teclis82 @ISIMMweb @AimmJournal Thank you for sharing. I always wanted to make a Miettinen style TMA. This is from his 2012 applied immunohistochemsitry paper.

[Andrew Bellizzi 🇺🇦 @IHC_guy]

I was recently teaching to a new student how a TMA is constructed. I thought a @YouTube video might help but found existing ones inadequate . . . when I remembered (doh!) that I had the amazing Wesley Estrada prepare one for my residents this past fall.

https://t.co/vXe5CkA5Rm

[Andrew Bellizzi 🇺🇦 @IHC_guy]

This is what I'll be reading this afternoon--a review of multiplex IHC/IF techniques:

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy https://t.co/21jdWqyw5s